Corrigendum to: Integrin signalling: The tug-of-war in heart hypertrophy [Cardiovascular Research 70 (2006) 422-433] (DOI:10.1016/j.cardiores.2005.12.015);Integrin signalling: The tug-of-war in heart hypertrophy

Cardiovascular Research

Volumn 70, Issue 3, 2006, Pages 422-433

  Brancaccio, Mara ^a,c   Hirsch, Emilio ^a,c   Notte, Antonella ^b   Selvetella, Giulio ^b   Lembo, Giuseppe ^b,d   Tarone, Guido ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b IRCCS NEUROMED   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cardiac hypertrophy; Integrins; Mechano transduction; Signal transduction

Indexed keywords

BETA INTEGRIN; FILAMIN; FOCAL ADHESION KINASE; INTEGRIN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAS PROTEIN; SCLEROPROTEIN; TALIN; VASODILATOR STIMULATED PHOSPHOPROTEIN; VINCULIN; ZYXIN;

AMINO ACID SEQUENCE; CARDIOMYOPATHY; CELL GROWTH; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; MECHANOTRANSDUCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 33646529418     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.09.002     Document Type: Erratum

References (84)

1. Tarone G., and Lembo G. Molecular interplay between mechanical and humoral signalling in cardiac hypertrophy. Trends Mol Med 9 (2003) 376-382
2. Frey N., and Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65 (2003) 45-79
3. O'Neill B.T., and Abel E.D. Akt1 in the cardiovascular system: friend or foe?. J Clin Invest 115 (2005) 2059-2064
4. Luo J., McMullen J.R., Sobkiw C.L., Zhang L., Dorfman A.L., Sherwood M.C., et al. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 25 (2005) 9491-9502
5. Patrucco E., Notte A., Barberis L., Selvetella G., Maffei A., Brancaccio M., et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118 (2004) 375-387
6. Sadoshima J., and Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59 (1997) 551-571
7. Pardo J.V., Siliciano J.D., and Craig S.W. A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci U S A 80 (1983) 1008-1012
8. Ross R.S. The extracellular connections: the role of integrins in myocardial remodeling. J Card Fail 8 (2002) S326-S331
9. Ross R.S., and Borg T.K. Integrins and the myocardium. Circ Res 88 (2001) 1112-1119
10. Ruwhof C., and van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 47 (2000) 23-37
11. Sugden P.H. Ras, Akt, and mechanotransduction in the cardiac myocyte. Circ Res 93 (2003) 1179-1192
12. Miranti C.K., and Brugge J.S. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4 (2002) E83-E90
13. Giancotti F.G., and Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19 (2003) 173-206
14. Carman C.V., and Springer T.A. Integrin avidity regulation: are changes in affinity and conformation underemphasized?. Curr Opin Cell Biol 15 (2003) 547-556
15. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
16. Brancaccio M., Cabodi S., Belkin A.M., Collo G., Koteliansky V.E., Tomatis D., et al. Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development. Cell Adhes Commun 5 (1998) 193-205
17. van der Flier A., Gaspar A.C., Thorsteinsdottir S., Baudoin C., Groeneveld E., Mummery C.L., et al. Spatial and temporal expression of the beta1D integrin during mouse development. Dev Dyn 210 (1997) 472-486
18. Belkin A.M., Retta S.F., Pletjushkina O.Y., Balzac F., Silengo L., Fassler R., et al. Muscle beta1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin adhesive function by alternative splicing. J Cell Biol 139 (1997) 1583-1595
19. Critchley D.R. Focal adhesions - the cytoskeletal connection. Curr Opin Cell Biol 12 (2000) 133-139
20. Wu C., and Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155 (2001) 505-510
21. Mackinnon A.C., Qadota H., Norman K.R., Moerman D.G., and Williams B.D. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 12 (2002) 787-797
22. Zervas C.G., Gregory S.L., and Brown N.H. Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol 152 (2001) 1007-1018
23. Sakai T., Li S., Docheva D., Grashoff C., Sakai K., Kostka G., et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 17 (2003) 926-940
24. Brakebusch C., and Fassler R. The integrin-actin connection, an eternal love affair. EMBO J 22 (2003) 2324-2333
25. Chen H., Huang X.N., Yan W., Chen K., Guo L., Tummalapali L., et al. Role of the integrin-linked kinase/PINCH1/alpha-parvin complex in cardiac myocyte hypertrophy. Lab Invest 85 (2005) 1342-1356
26. Ling K., Doughman R.L., Iyer V.V., Firestone A.J., Bairstow S.F., Mosher D.F., et al. Tyrosine phosphorylation of type Igamma phosphatidylinositol phosphate kinase by Src regulates an integrin-talin switch. J Cell Biol 163 (2003) 1339-1349
27. Ling K., Doughman R.L., Firestone A.J., Bunce M.W., and Anderson R.A. Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. Nature 420 (2002) 89-93
28. Di Paolo G., Pellegrini L., Letinic K., Cestra G., Zoncu R., Voronov S., et al. Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 gamma by the FERM domain of talin. Nature 420 (2002) 85-89
29. Shai S.Y., Harpf A.E., Babbitt C.J., Jordan M.C., Fishbein M.C., Chen J., et al. Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 90 (2002) 458-464
30. Keller R.S., Shai S.Y., Babbitt C.J., Pham C.G., Solaro R.J., Valencik M.L., et al. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. Am J Pathol 158 (2001) 1079-1090
31. Pfaff M., Liu S., Erle D.J., and Ginsberg M.H. Integrin beta cytoplasmic domains differentially bind to cytoskeletal proteins. J Biol Chem 273 (1998) 6104-6109
32. Baudoin C., Goumans M.J., Mummery C., and Sonnenberg A. Knockout and knocking of the beta1 exon D define distinct roles for integrin splice variants in heart function and embryonic development. Genes Dev 12 (1998) 1202-1216
33. Kuppuswamy D., Kerr C., Narishige T., Kasi V.S., Menick D.R., and Cooper G.T. Association of tyrosine-phosphorylated c-Src with the cytoskeleton of hypertrophying myocardium. J Biol Chem 272 (1997) 4500-4508
34. Willey C.D., Balasubramanian S., Rodriguez Rosas M.C., Ross R.S., and Kuppuswamy D. Focal complex formation in adult cardiomyocytes is accompanied by the activation of beta3 integrin and c-Src. J Mol Cell Cardiol 35 (2003) 671-683
35. Balasubramanian S., and Kuppuswamy D. RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells. J Biol Chem 278 (2003) 42214-42224
36. Sun M., Opavsky M.A., Stewart D.J., Rabinovitch M., Dawood F., Wen W.H., et al. Temporal response and localization of integrins beta1 and beta3 in the heart after myocardial infarction: regulation by cytokines. Circulation 107 (2003) 1046-1052
37. Chun T.Y., Bloem L., and Pratt J.H. Spironolactone increases integrin beta3 gene expression in kidney and heart muscle cells. Mol Cell Endocrinol 194 (2002) 175-182
38. Laser M., Willey C.D., Jiang W., Cooper G.t., Menick D.R., Zile M.R., et al. Integrin activation and focal complex formation in cardiac hypertrophy. J Biol Chem 275 (2000) 35624-35630
39. Graf K., and Stawowy P. Osteopontin: a protective mediator of cardiac fibrosis?. Hypertension 44 (2004) 809-810
40. Rysa J., Leskinen H., Ilves M., and Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 45 (2005) 927-933
41. Mitra S.K., Hanson D.A., and Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6 (2005) 56-68
42. Franchini K.G., Torsoni A.S., Soares P.H., and Saad M.J. Early activation of the multicomponent signaling complex associated with focal adhesion kinase induced by pressure overload in the rat heart. Circ Res 87 (2000) 558-565
43. Domingos P.P., Fonseca P.M., Nadruz Jr. W., and Franchini K.G. Load-induced focal adhesion kinase activation in the myocardium: role of stretch and contractile activity. Am J Physiol Heart Circ Physiol 282 (2002) H556-H564
44. Torsoni A.S., Constancio S.S., Nadruz Jr. W., Hanks S.K., and Franchini K.G. Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes. Circ Res 93 (2003) 140-147
45. Heidkamp M.C., Bayer A.L., Kalina J.A., Eble D.M., and Samarel A.M. GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes. Circ Res 90 (2002) 1282-1289
46. Pham C.G., Harpf A.E., Keller R.S., Vu H.T., Shai S.Y., Loftus J.C., et al. Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway. Am J Physiol Heart Circ Physiol 279 (2000) H2916-H2926
47. Taylor J.M., Rovin J.D., and Parsons J.T. A role for focal adhesion kinase in phenylephrine-induced hypertrophy of rat ventricular cardiomyocytes. J Biol Chem 275 (2000) 19250-19257
48. Govindarajan G., Eble D.M., Lucchesi P.A., and Samarel A.M. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells. Circ Res 87 (2000) 710-716
49. Eble D.M., Strait J.B., Govindarajan G., Lou J., Byron K.L., and Samarel A.M. Endothelin-induced cardiac myocyte hypertrophy: role for focal adhesion kinase. Am J Physiol Heart Circ Physiol 278 (2000) H1695-H1707
50. Kovacic-Milivojevic B., Roediger F., Almeida E.A., Damsky C.H., Gardner D.G., and Ilic D. Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy. Mol Biol Cell 12 (2001) 2290-2307
51. Ross R.S., Pham C., Shai S.Y., Goldhaber J.I., Fenczik C., Glembotski C.C., et al. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res 82 (1998) 1160-1172
52. Bayer A.L., Heidkamp M.C., Patel N., Porter M.J., Engman S.J., and Samarel A.M. PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 283 (2002) H695-H706
53. Melendez J., Welch S., Schaefer E., Moravec C.S., Avraham S., Avraham H., et al. Activation of pyk2/related focal adhesion tyrosine kinase and focal adhesion kinase in cardiac remodeling. J Biol Chem 277 (2002) 45203-45210
54. Heidkamp M.C., Scully B.T., Vijayan K., Engman S.J., Szotek E.L., and Samarel A.M. PYK2 regulates SERCA2 gene expression in neonatal rat ventricular myocytes. Am J Physiol Cell Physiol 289 (2005) C471-C482
55. Brancaccio M., Guazzone S., Menini N., Sibona E., Hirsch E., De Andrea M., et al. Melusin is a new muscle-specific interactor for beta(1) integrin cytoplasmic domain. J Biol Chem 274 (1999) 29282-29288
56. Brancaccio M., Menini N., Bongioanni D., Ferretti R., De Acetis M., Silengo L., et al. Chp-1 and melusin, two CHORD containing proteins in vertebrates. FEBS Lett 551 (2003) 47-52
57. Brancaccio M., Fratta L., Notte A., Hirsch E., Poulet R., Guazzone S., et al. Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med 9 (2003) 68-75
58. De Acetis M., Notte A., Accornero F., Selvetella G., Brancaccio M., Vecchione C., et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload. Circ Res 96 (2005) 1087-1094
59. Dorn II G.W., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115 (2005) 527-537
60. Condorelli G., Drusco A., Stassi G., Bellacosa A., Roncarati R., Iaccarino G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 99 (2002) 12333-12338
61. Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19 (2000) 2537-2548
62. Matsui T., Li L., Wu J.C., Cook S.A., Nagoshi T., Picard M.H., et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277 (2002) 22896-22901
63. Ceci M., Ross Jr. J., and Condorelli G. Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT. J Mol Cell Cardiol 37 (2004) 905-912
64. Marian A.J. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 17 (2002) 242-252
65. Xu W., Baribault H., and Adamson E.D. Vinculin knockout results in heart and brain defects during embryonic development. Development 125 (1998) 327-337
66. Zemljic-Harpf A.E., Ponrartana S., Avalos R.T., Jordan M.C., Roos K.P., Dalton N.D., et al. Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy. Am J Pathol 165 (2004) 1033-1044
67. Moiseyeva E.P., Weller P.A., Zhidkova N.I., Corben E.B., Patel B., Jasinska I., et al. Organization of the human gene encoding the cytoskeletal protein vinculin and the sequence of the vinculin promoter. J Biol Chem 268 (1993) 4318-4325
68. Olson T.M., Illenberger S., Kishimoto N.Y., Huttelmaier S., Keating M.T., and Jockusch B.M. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105 (2002) 431-437
69. Maeda M., Holder E., Lowes B., Valent S., and Bies R.D. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 95 (1997) 17-20
70. Vasile VC, Will ML, Ommen SR, Edwards WD, Olson TM, Ackerman MJ. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol Genet Metab in press (Available online 19 October 2005, doi:10.1016/j.ymgme.2005.08.06).
71. Beckerle M.C. Zyxin: zinc fingers at sites of cell adhesion. Bioessays 19 (1997) 949-957
72. Krause M., Dent E.W., Bear J.E., Loureiro J.J., and Gertler F.B. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19 (2003) 541-564
73. Hoffman L.M., Nix D.A., Benson B., Boot-Hanford R., Gustafsson E., Jamora C., et al. Targeted disruption of the murine zyxin gene. Mol Cell Biol 23 (2003) 70-79
74. Lanier L.M., Gates M.A., Witke W., Menzies A.S., Wehman A.M., Macklis J.D., et al. Mena is required for neurulation and commissure formation. Neuron 22 (1999) 313-325
75. Hauser W., Knobeloch K.P., Eigenthaler M., Gambaryan S., Krenn V., Geiger J., et al. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci U S A 96 (1999) 8120-8125
76. Eigenthaler M., Engelhardt S., Schinke B., Kobsar A., Schmitteckert E., Gambaryan S., et al. Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 285 (2003) H2471-H2481
77. Wollert K.C., Fiedler B., Gambaryan S., Smolenski A., Heineke J., Butt E., et al. Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension 39 (2002) 87-92
78. Wu C. Migfilin and its binding partners: from cell biology to human diseases. J Cell Sci 118 (2005) 659-664
79. Akazawa H., Kudoh S., Mochizuki N., Takekoshi N., Takano H., Nagai T., et al. A novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5. J Cell Biol 164 (2004) 395-405
80. Kasahara H., Lee B., Schott J.J., Benson D.W., Seidman J.G., Seidman C.E., et al. Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 106 (2000) 299-308
81. Thompson J.T., Rackley M.S., and O'Brien T.X. Upregulation of the cardiac homeobox gene Nkx2-5 (CSX) in feline right ventricular pressure overload. Am J Physiol 274 (1998) H1569-H1573
82. Saadane N., Alpert L., and Chalifour L.E. Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol 127 (1999) 1165-1176
83. Yamamoto K., Dang Q.N., Maeda Y., Huang H., Kelly R.A., and Lee R.T. Regulation of cardiomyocyte mechanotransduction by the cardiac cycle. Circulation 103 (2001) 1459-1464
84. Miyamoto T., Takeishi Y., Takahashi H., Shishido T., Arimoto T., Tomoike H., et al. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload. Basic Res Cardiol 99 (2004) 328-337